M. Sakumura

Small intestinal mucosal injury in patients with gastrointestinal cancer who develop complicated fluoropyrimidine-induced diarrhea

I. Yasuda, I. Motoo, T. Ando, 2020 .

Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea

I. Yasuda, I. Motoo, T. Ando, 2020, BMC Gastroenterology.

Efficacy and Safety of FOLFOX in Advanced Gastric Cancer Initially Presenting With Disseminated Intravascular Coagulation

I. Motoo, T. Ando, S. Kajiura, 2022, In Vivo.

Bilateral Serous Retinal Detachment Associated with a Mitogen-activated Protein KinaseKinase Inhibitor in a Patient with BRAF-mutant Colorectal Cancer

I. Yasuda, I. Motoo, T. Ando, 2021, Internal medicine.

Colonic TRPV4 overexpression is related to constipation severity

Yoshiyuki Watanabe, F. Itoh, M. Minemura, 2023, BMC Gastroenterology.

A Review of Potential Role of Capsule Endoscopy in the Work-Up for Chemotherapy-Induced Diarrhea

I. Yasuda, T. Ando, H. Mihara, 2022, Healthcare.

Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer

T. Fujii, T. Miwa, I. Motoo, 2022, Oncology.

Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma

T. Sugiyama, K. Arita, K. Tajiri, 2017, Internal medicine.

Intensive surveillance endoscopy for multiple gastrointestinal tumors in a patient with constitutional mismatch repair deficiency: case report

T. Fujii, I. Yasuda, Y. Niida, 2021, BMC Gastroenterology.

Gastric Metastasis of Hepatocellular Carcinoma Mimicking Early Gastric Cancer.

T. Sugiyama, K. Tajiri, Miho Sakumura, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer

I. Motoo, T. Ando, S. Kajiura, 2023, Frontiers in oncology.

The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis

I. Motoo, S. Kajiura, A. Hosokawa, 2024, Journal of clinical medicine.

CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer

I. Motoo, S. Kajiura, A. Hosokawa, 2024, Cancers.